Metraipolis › archive › dc_61e728cd44ba
Single-cell imaging analysis, therapeutic modeling and a Phase Ib trial validate BCL-2 as a target across heterogeneous castration-resistant prostate cancer — Europe PMC PMID:42067541
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42067541
- DOI
- 10.1038/s41392-[numero omesso]-w
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-02T22:50:45.914Z
- SHA-256 of the archived text
c1c9f3cb11962b55c74ad04c767e578b1ddbfbac048ed237eb376eeffede4210- Stable URL of this page
https://metraipolis.com/documento/dc_61e728cd44ba
How to cite
Single-cell imaging analysis, therapeutic modeling and a Phase Ib trial validate BCL-2 as a target across heterogeneous castration-resistant prostate cancer — Europe PMC PMID:42067541 — Europe PMC (en), https://europepmc.org/article/MED/42067541 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_61e728cd44ba (Metraipolis archive dc_61e728cd44ba, sha256 c1c9f3cb11962b55c74ad04c767e578b1ddbfbac048ed237eb376eeffede4210)
BibTeX
@misc{dc61e728cd44ba,
title = {Single-cell imaging analysis, therapeutic modeling and a Phase Ib trial validate BCL-2 as a target across heterogeneous castration-resistant prostate cancer — Europe PMC PMID:42067541},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42067541},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_61e728cd44ba; sha256 c1c9f3cb11962b55c74ad04c767e578b1ddbfbac048ed237eb376eeffede4210},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42067541. Agents can read the archived copy with the MCP tool read_document.